Skip to content

Drug interactions

Eltrombopag + Ozanimod

Severity: Moderate

Eltrombopag and Ozanimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eltrombopag inhibits BCRP, which may raise exposure to the active metabolites of ozanimod. This could increase adverse effects such as bradycardia, hepatic enzyme elevation and infections.

What this interaction means in plain words

Eltrombopag and Ozanimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eltrombopag belongs to Miscellaneous; Ozanimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

BCRP inhibition by eltrombopag may reduce efflux of ozanimod active metabolites and increase their exposure.

What to do

Monitor heart rate, liver enzymes and signs of infection when the drugs are combined. Consider an alternative if tolerability problems arise.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eltrombopag and Ozanimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eltrombopag with Ozanimod?

MediHelp rates the interaction as moderate. Eltrombopag and Ozanimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eltrombopag inhibits BCRP, which may raise exposure to the active metabolites of ozanimod. This could increase adverse effects such as bradycardia, hepatic enzyme elevation and infections.

How serious is the interaction between Eltrombopag and Ozanimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate, liver enzymes and signs of infection when the drugs are combined. Consider an alternative if tolerability problems arise.

What other medicines interact with Eltrombopag?

MediHelp also lists interactions of Eltrombopag with, for example, Alpelisib, Aluminum hydroxide, Amobarbital. The full list is on the Eltrombopag page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in